Assessing the Role of Immunomodulators in IBD

Crohn’s & Colitis Congress 2021: Assessing the Role of Immunomodulators in IBD

ReachMD Healthcare Image
RestartResume

What role do immunomodulators play in the management of inflammatory bowel disorders and how should we incorporate them into our practice?

  • Overview

    With current treatment approaches in mind, how do immunomodulators fit into the therapeutic landscape for inflammatory bowel disorders, or IBD? In preparation for the 2021 Crohn’s & Colitis Congress, Dr. Charles Turck speaks with Dr. Maria Oliva-Hemker from Johns Hopkins University School of Medicine about her presentation at the event. 

Facebook Comments

Register

We’re glad to see you’re enjoying Crohn's Colitis Professional…
but how about a more personalized experience?

Register for free